Arkolith/Insider Trading/ELYM/Form 4

Morisset Valerie

EVP, R&D AND CSOEliem Therapeutics, Inc. (ELYM) · full profile →Form 4 · filed Jul 3, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$338K
Net Open-Market Flow
-$338K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 3, 2024Sell(S)50K$6.76$338K463K
Jul 1, 2024Option exercise(M)8K—$0513K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 1, 2024Option exercise(M)8K—$010K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-019147) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML